Affordable Access

Publisher Website

PTEN in cancer, metabolism, and aging

Authors
Journal
Trends in Endocrinology and Metabolism
1043-2760
Publisher
Elsevier
Volume
24
Issue
4
Identifiers
DOI: 10.1016/j.tem.2012.11.002
Keywords
  • Pten
  • Cancer
  • Aging
  • Metabolism
  • Brown Adipose Tissue
  • Warburg Effect
Disciplines
  • Biology
  • Computer Science
  • Medicine

Abstract

Recent reports on mice with systemic overexpression of the tumor-suppressor PTEN (phosphatase and tensin homolog) have expanded our understanding of its physiological functions. Pten transgenic mice present increased energy expenditure, decreased adiposity, improved insulin sensitivity upon high-fat feeding or with aging, and extended lifespan. This has led to new mechanistic insights about the role of PTEN in metabolism. Interestingly, PTEN promotes oxidative phosphorylation and decreases glycolysis, thus preventing the metabolic reprogramming characteristic of cancer cells, which might be relevant to PTEN-mediated cancer protection. PTEN also upregulates UCP1 expression in brown adipocytes, which enhances their nutrient burning capacity and decreases adiposity and associated pathologies. The newly discovered effects of PTEN on metabolism open new avenues for exploration relevant to cancer, obesity, diabetes, and aging.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments

More articles like this

PTEN--linking metabolism, cell growth, and cancer.

on New England Journal of Medicin... Sep 13, 2012

PTEN and cancer.

on Methods in Molecular Biology 2003

mTOR in aging, metabolism, and cancer

on Current Opinion in Genetics &...
More articles like this..